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Chikungunya Fever, 
Mauritius, 2006 
To the Editor: When an out-
break of chikungunya fever swept 
across several Indian Ocean islands 
in 2005 and 2006, the international 
public health community’s attention 
was drawn to chikungunya virus (ge-
nus Alphavirus, family Togaviridae). 
Among those areas affected was the 
Republic of Mauritius, located ≈900 
km east of Madagascar, which has an 
estimated population of 1,250,000 and 
comprises the main island of Mauritius 
(area ≈1,865 km2) and several outly-
ing islands including Rodrigues (≈180 
km2). Mauritius Island had an initial 
outbreak of ≈3,500 suspected cases of 
chikungunya fever from April through 
June 2005 (1). With the onset of the 
drier season of winter, transmission of 
the virus subsided, but increased again 
during 2006. An outbreak began on 
Rodrigues Island in February 2006. 
The intensity of chikungunya fever 
outbreaks on Mauritius and Rodrigues 
Islands led us to explore the extent 
to which these outbreaks might have 
contributed to overall death rates.
Chikungunya virus is transmitted 
to humans primarily by the bite of in-
fected Aedes spp. mosquitoes. Aedes 
aegypti was effectively eliminated 
from the island of Mauritius during a 
malaria control campaign from 1949 
through 1951 (2). However, A.  al-
bopictus is widely distributed on the 
island in rural and urban habitats (3); 
thus, A. albopictus may be the most 
likely vector for chikungunya virus. 
Common peridomestic breeding plac-
es in Mauritius include small pots and 
vases (used to decorate the outside of 
homes) and discarded rubber tires (3).
Chikungunya fever was ﬁ  rst rec-
ognized in 1952 after an outbreak on 
the Makonde Plateau of Tanganyika 
Territory (4), currently part of Tan-
zania. The word chikungunya is from 
a local dialect that translates to “that 
which bends up” in reference to the 
stooped posture often seen in patients 
with severe arthralgia (5). Human in-
fections with chikungunya virus are 
associated with sudden onset of symp-
toms including headache, fever, rash, 
and muscle and joint pain (5). Before 
the outbreak in the Indian Ocean is-
lands, deaths had not been associated 
with infections. However, Réunion 
Island reported >200 deaths dur-
ing the 2006 chikungunya epidemic 
(January–April 2006) (6), and India 
conservatively estimated 1,194 deaths 
since the virus reemerged in Decem-
ber 2005. (7). To determine whether 
a similar situation occurred in Mau-
ritius, we compared expected number 
of deaths with observed number of 
deaths and estimated number of chi-
kungunya cases from January through 
December 2006.
Crude death rates (CDRs) and 
number of deaths were obtained from 
the Annual Digest of Statistics 2005 
and 2006 (8). We calculated expect-
ed number of deaths for each month 
in 2006 by multiplying mean CDR 
(per 1,000 midyear population) of 
each month for the previous 10 years 
(1996–2005) by midyear population 
for 2006. Estimated number of cases 
of chikungunya fever in 2006 for the 
Island of Mauritius was obtained from 
the Chikungunya Unit of the Ministry 
of Health and Quality of Life and in-
cludes both suspected and conﬁ  rmed 
cases. A case was considered suspect-
ed if the patient had >2 of the follow-
ing 3 symptoms: fever, rash, and joint 
pain. Cases were conﬁ   rmed by cell 
culture.
CDRs for the Republic of Mau-
ritius ranged from 6.7 to 7.0 during 
1996–2005 (mean  6.8) but increased 
to 7.3 in 2006, which represented a 
4.3% (95% conﬁ   dence interval [CI] 
2.2%–8.5%) increase from 2005 
(CDR 7.0). According to the 2006 
midyear Population and Vital Statis-
tics Report for the Republic of Mau-
ritius (8), the number of deaths from 
January through June 2006 increased 
by 16.7% (95% CI 11.0%–23.5%) 
over the number of deaths in 2005, 
and 19.8% (95% CI 13.5%–26.9%) 
more deaths occurred among elderly 
persons (age >60 years). These num-
bers include all potential causes of 
deaths. However, increased CDRs oc-
curred only during the months of the 
chikungunya fever epidemic on Rod-
grigues and Mauritius Islands.
CDRs on the Island of Mauritius 
in March, April, and May 2006 were 
signiﬁ   cantly greater than expected 
(p<0.01 for all 3 months); this corre-
sponds to 743 excess deaths for these 
months (Figure). The chikungunya 
fever epidemic in Mauritius began ≈1 
month before the ﬁ  rst month of report-
ed excess deaths; 4,871 cases of chi-
kungunya fever cases were reported in 
February, 5,084 in March, and 2,305 
in April. Rodrigues Island showed a 
similar trend, with an increase in the 
number of observed deaths in April, 
May, and June (p<0.01 for May). 
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 2, February 2008  337 
Figure. Expected and observed numbers of deaths and estimated number of chikungunya 
cases on Mauritius Island. Asterisks indicate a statistically signiﬁ  cant (p<0.01) difference 
between expected and observed number of deaths for the speciﬁ  ed months. Vertical lines 
show 95% conﬁ  dence intervals; upper conﬁ  dence limits are shown numerically.LETTERS
The  ﬁ  rst  conﬁ   rmed case of chikun-
gunya fever on Rodrigues Island was 
reported in February, followed by 56 
cases in March, 393 in April, and >80 
in May (9).
The increase in CDRs reported for 
the Republic of Mauritius during the 
chikungunya epidemic is similar to the 
ﬁ  ndings reported for the neighboring 
island of Réunion (10). Excess deaths 
in Réunion and the Republic of Mauri-
tius coincided with the epidemic curve 
of the chikungunya fever outbreak, 
which suggested an association be-
tween these 2 factors. No other events 
that may have negatively affected the 
health of persons living in the Repub-
lic of Mauritius in 2006 were report-
ed. However, because information on 
cause of death is unavailable, studies 
are needed to conﬁ  rm that the chikun-
gunya fever outbreak contributed to 
increased CDRs in 2006.
Acknowledgments
We thank Amita Pathack for provid-
ing data on the estimated number of chi-
kungunya fever cases in Mauritius; Ra-
heem Gopaul, Kevin Sullivan, and Brent 
Moll for assistance with preparing this 
article; and the director of the Central Sta-
tistical Ofﬁ  ce in Mauritius for providing 
demographic statistics.
Sanjay Beesoon,* 
Ellen Funkhouser,† 
Navaratnam Kotea,* 
Andrew Spielman,‡1 
and Rebecca M. Robich‡
*University of Mauritius, Reduit, Mauritius; 
†University of Alabama at Birmingham 
School of Medicine, Birmingham, Alabama, 
USA; and ‡Harvard School of Public Health, 
Boston, Massachusetts, USA
References
  1.   Issack  M.  Chikungunya-Mauritius  and 
Reunion Island (07). ProMed. February 4, 
2006 [cited 2007 Nov 13]. Available from 
http://www.promedmail.org, archive no. 
20060204.0358.
  2.   Dowling MA. Control of malaria in Mau-
ritius; eradication of Anopheles funestus 
and Aedes aegypti. Trans R Soc Trop Med 
Hyg. 1953;47:177–98.
  3.   Gopaul  AR.  The  common  man-biting 
mosquitoes (Diptera: Culicidae) of Mau-
ritius. The Mauritius Institute Bulletin. 
2003;11:9–19.
  4.   Lumsden WH. An epidemic of virus dis-
ease in Southern Province, Tanganyika 
Territory, in 1952–53. II. General descrip-
tion and epidemiology. Trans R Soc Trop 
Med Hyg. 1955;49:33–57.
  5.   Robinson MC. An epidemic of virus dis-
ease in Southern Province, Tanganyika 
Territory, in 1952–53. I. Clinical features. 
Trans R Soc Trop Med Hyg. 1955;49:28–
32.
  6.   Flahault  M.  Chikungunya-Indian  Ocean 
Update (32). ProMed. October 14, 2006 
[cited 2007 Nov 20]. Available from 
http://www.promedmail.org, archive no. 
20061014.2953.
  7.   Mavalankar D, Shastri P, Raman P. Chi-
kungunya epidemic in India: a major 
public-health disaster. Lancet Infect Dis. 
2007;7:306–7.
    8.    Republic of Mauritius Central Statistics 
Ofﬁ   ce. Population and vital statistics. 
2007. [cited 2007 Nov 13]. Available from 
http://www.gov.mu/portal/site/cso
  9.   Oral answers to questions. Rodrigues-chi-
kungunya cases (No. B/582). 2006. [cited 
2007 Nov 13]. Available from www.gov.
mu/portal/goc/assemblysite/file/orans-
23may06.pdf
10.   Josseran L, Paquet C, Zehgnoun A, 
Caillere N, Le Tertre A, Solet J, et al. Chi-
kungunya disease outbreak, Reunion Is-
land. Emerg Infect Dis. 2006;12:1994–5.
Address for correspondence: Rebecca M. 
Robich, Department of Immunology and 
Infectious Diseases, Harvard School of Public 
Health, 665 Huntington Ave, Boston, MA 
02115, USA; email: rrobich@hsph.harvard.edu
Increasing 
Resistance in 
Commensal 
Escherichia coli, 
Bolivia and Peru
To the Editor: The global in-
crease of antimicrobial-drug resis-
tance, including resistance to the new 
and most potent antimicrobial agents, 
is a major public health concern. In 
low-resource countries, where bacte-
rial infections are still among the ma-
jor causes of death, especially for chil-
dren, it is of particular concern (1).
ANTRES (Towards Controlling 
Antimicrobial Use and Resistance in 
Low-income Countries—An Interven-
tion Study in Latin America) is a re-
search project on antimicrobial-drug 
use and resistance in low-resource coun-
tries of Latin America (see www.uniﬁ  .
it/infdis/antres/default.htm). In 2002,
 the baseline ANTRES study showed a 
high rate of fecal carriage of Escherich-
ia coli with acquired resistance to sever-
al antimicrobial drugs, especially older 
drugs (e.g., ampicillin, trimethoprim-
sulfamethoxazole, tetracycline, strep-
tomycin, and chloramphenicol), in 
preschool children from 4 urban set-
tings in Bolivia and Peru (2). We report 
the results of a second cross-sectional 
study, conducted in 2005, that evalu-
ated the evolution of antimicrobial-
drug resistance in the studied areas.
We studied healthy children 6–72 
months of age from each of 4 urban ar-
eas:  2 in Bolivia (Camiri, Santa Cruz 
Department; Villa Montes, Tarija De-
partment) and 2 in Peru (Yurimaguas, 
Loreto Department; Moyobamba, San 
Martin Department). The study design, 
sampling and inclusion criteria, meth-
ods, and ethical issues were the same 
as those of the baseline study (2). The 
study was carried out over 4 months 
(September–December 2005), the 
same seasonal period as in the previ-
ous study. No signiﬁ  cant  differences 
in sex ratios were found among chil-
dren enrolled from the different areas, 
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